Chlamydia Infections Clinical Trial
Official title:
Partner Notification for Chlamydia in Primary Care: Randomised Controlled Trial and Economic Evaluation
Verified date | January 2018 |
Source | University of Bristol |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study was to compare the effectiveness of partner notification by general practice nurses with referral to a specialist clinic for people with genital chlamydia diagnosed in a community setting. We hypothesised that referral to a specialist would be more effective in ensuring treatment of the sexual partners of infected people than the simpler nurse-led strategy.
Status | Completed |
Enrollment | 214 |
Est. completion date | December 2002 |
Est. primary completion date | |
Accepts healthy volunteers | No |
Gender | All |
Age group | 16 Years and older |
Eligibility |
Inclusion Criteria: - Chlamydia trachomatis diagnosed through a population-based screening study - Chlamydia test result received at patient's general practice - Chlamydia cases diagnosed in general practice Exclusion Criteria: |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Chlamydia Screening Studies (ClaSS) project general practices | Birmingham | West Midlands |
United Kingdom | Chlamydia Screening Studies (ClaSS) project general practices | Bristol | Avon |
Lead Sponsor | Collaborator |
---|---|
University of Bristol |
United Kingdom,
Low N, McCarthy A, Macleod J, Salisbury C, Horner PJ, Roberts TE, Campbell R, Herring A, Skidmore S, Sanford E, Sterne JA, Davey Smith G, Graham A, Huengsberg M, Ross J, Egger M. The chlamydia screening studies: rationale and design. Sex Transm Infect. 2004 Oct;80(5):342-8. — View Citation
Low N, McCarthy A, Roberts TE, Huengsberg M, Sanford E, Sterne JA, Macleod J, Salisbury C, Pye K, Holloway A, Morcom A, Patel R, Robinson SM, Horner P, Barton PM, Egger M. Partner notification of chlamydia infection in primary care: randomised controlled — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Percentage of index cases with at least one sexual partner treated | |||
Primary | Number of sexual partners per index case treated | |||
Secondary | Number of sexual partners per index case elicited during sexual history taking | |||
Secondary | Positive chlamydia test result six weeks after treatment | |||
Secondary | Adherence to advice to abstain from sexual intercourse until both partners completed treatment |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00381992 -
Risk Assessment of Long-Haul Truck Drivers
|
N/A | |
Completed |
NCT00115388 -
Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease
|
N/A | |
Completed |
NCT00005496 -
Inflammation, Infection, and Future Cardiovascular Risk
|
N/A | |
Completed |
NCT00207506 -
Lay Health Advisors for Sexually Transmitted Disease Prevention
|
Phase 1/Phase 2 | |
Completed |
NCT00132457 -
Use of Self-collected Vaginal Swabs as an Innovative Approach to Facilitate Testing for Repeat Chlamydia Infection
|
N/A | |
Completed |
NCT03073538 -
Screening of Gonococcal and Chlamydial Infections in the Third Trimester
|
||
Terminated |
NCT00120770 -
Cellulose Sulfate (CS) Gel and HIV in Nigeria
|
Phase 3 | |
Completed |
NCT00001890 -
Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections
|
Phase 2 | |
Not yet recruiting |
NCT05727033 -
Extraordinarily Fun Training Project in Compulsory Secondary Education - Sexually Transmitted Infections
|
N/A | |
Completed |
NCT00561028 -
Chlamydia and Mycoplasma in Coronary Artery Disease
|
N/A | |
Completed |
NCT00252096 -
Nucleic Acid Amplification Tests (NAATs) for the Diagnosis of Pharyngeal and Rectal Chlamydia and Gonorrhea Infections
|
N/A | |
Completed |
NCT00037388 -
Pediatrics:Chlamydia, Sickle Cell Anemia and Stroke Risk - Ancillary to STOP II
|
N/A | |
Terminated |
NCT01728103 -
Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays
|
N/A | |
Completed |
NCT00607659 -
Immunopathogenesis of Chlamydia
|
N/A | |
Completed |
NCT00000120 -
Clinical Trial of Eye Prophylaxis in the Newborn
|
Phase 3 | |
Completed |
NCT01638637 -
Prospective Collection of Female and Male Specimens for PANTHER® System Testing
|
N/A | |
Completed |
NCT03374696 -
Theater in School Sex Education - a Randomized Controlled Study
|
N/A | |
Active, not recruiting |
NCT00124878 -
Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the Community
|
Phase 3 | |
Completed |
NCT00005547 -
Infection and Cardiovascular Disease
|
N/A |